Fabtech Technologies IPO subscribed overall 740.37 times on the last day, a retail quota was subscribed over 715.05 times, and NII was subscribed over 1,485.52 times respectively.
Details About Fabtech Technologies IPO
Fabtech Technologies got approval from SEBI for an IPO of around ₹27.74 crores, an entirely fresh issue with a face value of Rs 10 each. Further, it had a set price band between ₹80 to ₹85 per share.
In this IPO 1,600 shares were in 1 lot size for retail minimum and maximum category. Moreover, 3,200 shares were in 2 lot sizes for the S-HNI category.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum and maximum investment of ₹1,36,000.
- SHNI (S-HNI): Minimum investment of ₹2,72,000.
Fabtech Technologies IPO’s Subscription Duration
Fabtech Technologies IPO was started on January 3, 2025, and closed on January 7, 2025. The Fabtech Technologies IPO’s allotment date was January 08, 2025, and they received a refund on January 09, 2025. The listing of this IPO is on January 10, 2025.
Funds Deployment of This IPO
- The funds raised from the IPO will be utilized to cover the long term working capital requirements.
- The proposed funds will be used to buy shares of Kelvin Air Conditioning and Ventilation Systems Pvt. Ltd.
- While the remaining funds will be used for the company’s General corporate purposes.
About Fabtech Technologies Company
Founded in 2015, Fabtech Technologies Limited is one of the leading companies that manufacture, design, and offer modular panels and doors for cleanrooms, especially for pharmaceutical, healthcare, and biotech industries. Cleanrooms are a designed environment that is crafted with controlled levels of dust, airborne particles, temperature, and humidity. Pharmaceutical, healthcare, and biotech industries are some of the industries, cleanrooms mainly used in. The company designed their cleanrooms by keeping the customers requirements in mind and with global regulatory standards. Design to validation, encompassing engineering, manufacturing, quality assurance, timely delivery, installation, commissioning, and validation and certification, are some of the extensive services the company provides. Unichem Laboratories Ltd, Desano Pharmaceuticals Private Limited Apitoria Pharma Pvt Ltd (a 100% subsidiary of Aurobindo Pharma Ltd), Hamdard Laboratories (India), amongst others are the key customers of Fabtech technologies. Their 70,000 square foot manufacturing facility is situated in Umbergaon, Valsad, Gujarat.
Financial Resort of the Fabtech Technologies Company
In FY2024, Fabtech Technologies company reported a revenue of ₹97.99 crores, against the company generating a revenue of ₹125.10 crore in 2023. In FY2024, the company declared a profit of ₹5.78 crores against a profit of ₹7.96 crores in 2023.
